Clinical Trial Update: Postmarketing Surveillance Study for Use of Menactra® in the Republic of Korea [Phase 4]

View source ↗

Summary

Postmarketing surveillance study (Phase 4) evaluating Menactra in the Republic of Korea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis
• Meningococcal Infections
• Meningococcal Meningitis

Drugs mentioned

• Menactra (Meningococcal conjugate vaccine (A, C, W, Y))

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Meningitis, Meningococcal Meningitis | Phase 4 | Status: COMPLETED